Status:

COMPLETED

A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Lead Sponsor:

AbbVie

Conditions:

Chronic Hepatitis C Virus (HCV) Infection Genotype 1

Eligibility:

All Genders

18-99 years

Phase:

PHASE3

Brief Summary

The purpose of this study was to evaluate the effect of treatment with ABT-450 co-formulated with ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333; 3-DAA regimen, with or without ribavirin (RBV) ...

Detailed Description

This study (TOPAZ-I; M14-423), was a Phase 3b, open-label, multicenter study conducted outside of the United States which, together with its companion study TOPAZ-II (M14-222; NCT 02167945) conducted ...

Eligibility Criteria

Inclusion

  • Males and females at least 18 years old at screening
  • Females must be post-menopausal for more than 2 years or surgically sterile or practicing acceptable forms of birth control
  • Chronic hepatitis C, genotype 1 infection
  • Males must be surgically sterile or agree to practice acceptable forms of birth control
  • Screening laboratory result indicating HCV genotype 1 infection

Exclusion

  • Use of contraindicated medications within 2 weeks of dosing
  • Abnormal laboratory tests
  • Current or past clinical evidence of Child-Pugh B or C classification or history of liver decompensation
  • Confirmed presence of hepatocellular carcinoma
  • History of solid organ transplant

Key Trial Info

Start Date :

October 30 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 13 2021

Estimated Enrollment :

1596 Patients enrolled

Trial Details

Trial ID

NCT02219490

Start Date

October 30 2014

End Date

May 13 2021

Last Update

April 7 2023

Active Locations (187)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 47 (187 locations)

1

CHU Bab El Oued /ID# 145420

Algiers, Algeria, 16000

2

CHU Bologhine Hospital /ID# 145421

Algiers, Algeria, 16000

3

CHU Mustapha Bacha /ID# 132130

Algiers, Algeria, 16000

4

St Vincent's Hospital Sydney /ID# 131001

Darlinghurst, New South Wales, Australia, 2010